{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T12:19:53Z","timestamp":1764937193998},"reference-count":22,"publisher":"Japanese Society of Internal Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,1,15]]},"DOI":"10.2169\/internalmedicine.5499-20","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T22:06:19Z","timestamp":1600466779000},"page":"251-257","source":"Crossref","is-referenced-by-count":5,"title":["Secondary Minimal Change Disease Due to Pancreatic Cancer Improved by Chemotherapy"],"prefix":"10.2169","volume":"60","author":[{"given":"Sakue","family":"Masuda","sequence":"first","affiliation":[{"name":"Department of Gastroenterology Medicine Center, Shonan Kamakura General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Koizumi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Medicine Center, Shonan Kamakura General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidekazu","family":"Moriya","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shonan Kamakura General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Nishino","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Medicine Center, Shonan Kamakura General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruki","family":"Uojima","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Internal Medicine, Kitasato University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiko","family":"Tazawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Medicine Center, Shonan Kamakura General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Medicine Center, Shonan Kamakura General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Tasaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Medicine Center, Shonan Kamakura General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikamasa","family":"Ichita","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Medicine Center, Shonan Kamakura General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Medicine Center, Shonan Kamakura General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Kako","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Medicine Center, Shonan Kamakura General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumi","family":"Hidaka","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shonan Kamakura General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madoka","family":"Kudo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Shonan Kamakura General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"2. Cameron JS. The nephrotic syndrome and its complications. Am J Kidney Dis 10: 157-171, 1987.","DOI":"10.1016\/S0272-6386(87)80170-1"},{"key":"2","doi-asserted-by":"crossref","unstructured":"3. Glassock RJ. Secondary minimal change disease. Nephrol Dial Transplant 18: vi52-vi58, 2003.","DOI":"10.1093\/ndt\/gfg1060"},{"key":"3","unstructured":"4. Jhaveri KD, Shah HH, Calderon K, Campenot ES, Radhakrishnan J. Glomerular diseases seen with cancer and chemotherapy: a narrative review. Kidney Int 84: 34-44, 2013."},{"key":"4","doi-asserted-by":"crossref","unstructured":"5. Whelan TV, Hirszel P. Minimal-change nephropathy associated with pancreatic carcinoma. Arch Intern Med 148: 975-976, 1988.","DOI":"10.1001\/archinte.148.4.975"},{"key":"5","doi-asserted-by":"crossref","unstructured":"6. Hirokawa M, Moriya T, Manabe T. Minimal change renal disease associated with thymoma and pancreatic carcinoma. Acta Pathol 36: 1075-1081, 1986.","DOI":"10.1111\/j.1440-1827.1986.tb00217.x"},{"key":"6","first-page":"2730","author":"ED Avner","year":"2016","unstructured":"7. Avner ED, Harmon WE, Niaudet P, Yoshikawa N, Emma F, Goldstein SL. Idiopathic nephrotic syndrome in children: clinical aspects. In: Pediatric Nephrology. 7th ed. Springer, Berlin, 2016: 2730.","journal-title":"Pediatric Nephrology","ISSN":"http:\/\/id.crossref.org\/issn\/0931-041X","issn-type":"print"},{"key":"7","unstructured":"8. Lewis JB, Neilson EG. Glomerular diseases. In: Harrison's Online [Internet]. 18th ed. Longo DL, Fauci AS, Kasper DL, et al., Eds. McGraw-Hill, New York, 2012. Available from: https:\/\/www.sohailuniversity.edu.pk\/wp-content\/uploads\/2018\/12\/Harrisons-Manual-of-Medicine-18th-Edition.pdf"},{"key":"8","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(74)91880-7","volume":"2","author":"RJ Shalhoub","year":"1974","unstructured":"9. Shalhoub RJ. Pathogenesis of lipid nephrosis: a disorder of T-cell function. Lancet 2: 556-560, 1974.","journal-title":"The Lancet","ISSN":"http:\/\/id.crossref.org\/issn\/0140-6736","issn-type":"print"},{"key":"9","unstructured":"10. Waldman M, Crew RJ, Valeri A, et al. Adult minimal-change disease: clinical characteristics, treatment, and outcomes. Clin J Am Soc Nephrol 2: 445-453, 2007."},{"key":"10","doi-asserted-by":"crossref","unstructured":"11. Kerlin BA, Ayoob R, Smoyer WE. Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease. Clin J Am Soc Nephrol 7: 513-520, 2012.","DOI":"10.2215\/CJN.10131011"},{"key":"11","doi-asserted-by":"crossref","unstructured":"12. Hogan J, Radhakrishman J. The treatment of minimal change disease in adults. J Am Soc Nephrol 24: 702-711, 2013.","DOI":"10.1681\/ASN.2012070734"},{"key":"12","unstructured":"13. Kofman T, Zhang SY, Copie-Bergman C, et al. Minimal change nephrotic syndrome associated with non-Hodgkin lymphoid disorders: a retrospective study of 18 cases. Medicine (Baltimore) 93: 350-358, 2014."},{"key":"13","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3109\/0886022X.2010.502275","volume":"32","author":"JY Li","year":"2010","unstructured":"14. Li JY, Yong TY, Kuss BJ, Klebe S, Kotasek D, Barbara JA. Malignant pleural mesothelioma with associated minimal change disease and acute renal failure. Renal Failure 32: 1012-1115, 2010.","journal-title":"Renal Failure","ISSN":"http:\/\/id.crossref.org\/issn\/0886-022X","issn-type":"print"},{"key":"14","doi-asserted-by":"crossref","unstructured":"15. Plager J, Stutzman L. Acute nephrotic syndrome as a manifestation of active Hodgkin's disease. Am J Med 50: 56-66, 1971.","DOI":"10.1016\/0002-9343(71)90205-1"},{"key":"15","unstructured":"16. Kramer P, Sizoo W, Twiss EE. Nephrotic syndrome in Hodgkin's disease. Neth J Med 24: 114-119, 1981."},{"key":"16","doi-asserted-by":"crossref","unstructured":"17. Nakayama S, Yokote T, Kobayashi K, et al. Minimal-change nephrotic syndrome preceding Hodgkin lymphoma by 5 years with expression of tumor necrosis factor alpha in Hodgkin-Reed-Sternberg cells. Hum Pathol 41: 1196-1199, 2010.","DOI":"10.1016\/j.humpath.2010.01.021"},{"key":"17","unstructured":"18. Audard V, Larousserie F, Grimbert P, et al. Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of 21 cases and review of the literature. Kidney Int 69: 2251-2260, 2006."},{"key":"18","unstructured":"19. Burstein DM, Korbet SM, Schwartz MM. Membranous glomerulonephritis and malignancy. Am J Kidney Dis 9: 23-26, 1993."},{"key":"19","unstructured":"20. Yildiz H, Andreea SI, Hoton D, Yombi JC. Minimal change disease associated with malignant pleural mesothelioma: case report and review of literature. BMJ Case Rep 2016: bcr2016217958, 2016."},{"key":"20","doi-asserted-by":"crossref","unstructured":"21. Vivarelli M, Massella L, Ruggiero B, Emma F. Minimal change disease. Clin J Am Soc Nephrol 12: 332-345, 2017.","DOI":"10.2215\/CJN.05000516"},{"key":"21","doi-asserted-by":"crossref","unstructured":"22. Vivarelli M, Moscaritolo E, Tsalkidis A, Massella L, Emma F. Time for initial response to steroids is a major prognostic factor in idiopathic nephrotic syndrome. J Pediatr 156: 965-971, 2010.","DOI":"10.1016\/j.jpeds.2009.12.020"},{"key":"22","doi-asserted-by":"crossref","unstructured":"23. Chen CL, Fang HC, Chou KJ, et al. Increased endothelin 1 expression in adult-onset minimal change nephropathy with acute renal failure. Am J Kidney Dis 45: 818-825, 2005.","DOI":"10.1053\/j.ajkd.2005.02.007"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/2\/60_5499-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T03:48:55Z","timestamp":1610768935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/2\/60_5499-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,15]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5499-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,15]]}}}